The elevating incidence rate of infectious diseases across the globe, the growing number of researches on infectious disease diagnosis and the elevating emphasis on Point-of-care testing, are boosting the Infectious Disease Diagnostics market.
The Global Infectious Disease Diagnostics market is forecast to reach USD 28.03 Billion by 2027, according to a new report by Reports and Data. Immediate diagnosis of infectious disease is the present need of the time due to evolving pathogens and increasing the occurrence rate of hospital-acquired infections. Government of various nations has been emphasizing on rapid diagnosis of infectious disease as a strategic priority like in the U.S. The global COVID-19 pandemic is another mentionable crucial factor that is boosting the demand for laboratory-based molecular testing capacity and reagents.
The COVID-19 Impact: One of the major impacts of COVID-19 on the market has been elevated demand for point-of-care immunodiagnostic tests. The development of these easy-to-use and rapid devices to support testing outside of laboratory settings has been a response of diagnostic test manufacturers to shortages of laboratory-based molecular testing capacity. These test kits are developed by manufacturers based either on detection, in serum or blood of antibodies caused due to the infection or identification of proteins from the coronavirus in respiratory samples. WHO supports the use of these point-of-care immunodiagnostic tests in research settings.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2956
The report provides comprehensive assessment of the market covering key elements such as revenue estimations, cost analysis, import/export, production and consumption trends, CAGR, gross margin, and supply demand patterns. It also sheds light on recent technological developments, product advancements, and research and development activities in the region.
The report examines the key players operating in the market along with their market position, market share, revenue, gross margin, and business strategies. SWOT analysis and Porter’s Five Forces Analysis are used to examine and assess the market and its players. It also covers recent mergers and acquisitions, joint ventures, collaborations, agreements, partnerships, and product launches and brand promotions.
Key companies profiled in the report include:
Becton, Dickinson and Company, Abbott Laboratories, Bio-Rad Laboratories, Biomérieux SA, Diasorin, Danaher Corporation, Meridian Bioscience, Luminex, Roche Diagnostics, and Siemens AG.
Market Segmentation by Types:
Product Type Outlook (Revenue, USD Billion; 2017-2027)
- Consumables
- Instruments analyzers
- Software services
Technology Outlook (Revenue, USD Billion; 2017-2027)
- Traditional diagnostic technique
- Molecular diagnostic technique
Disease Type Outlook (Revenue, USD Billion; 2017-2027)
- Hepatitis
- Hospital-Acquired Infections (HAIS)
- Human Immunodeficiency Virus (HIV)
- Tuberculosis (TB)
- Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
- Influenza
- Human Papillomavirus
- Others
End-user Outlook (Revenue, USD Billion; 2017-2027)
- Reference Laboratories
- Hospital/Clinical Laboratories
- Academic/Research Institutes
- Physician Offices
- Others
Order this report @ https://www.reportsanddata.com/report-pricing/2956
Regional analysis covers in-depth analysis of analysis of the revenue, market share, and growth rate of the global Infectious Disease Diagnostics market in each region for the forecast period of 2021-2028. The report covers production and consumption rate, current and emerging trends, import/export, supply and demand, and presence of key players in each region.
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
Further key findings from the report suggest
- In context to Product Type, the Consumables segment is projected to witness a considerable growth rate of 6.3% during the forecast period. The elevating demand for assays and reagents because of rising demand for IDD tests contributes to the growth rate witnessed by this segment. The increasing occurrence rate of infectious diseases like COVID-19 and growing geriatric population is resulting in increasing demand for IDD tests. The epidemic is resulting in the development of various commercial and in-house assays to detect the virus, which is also contributing to the growth rate witnessed by this segment.
- In regards to Technology, the Molecular diagnostic technique segment is projected to witness a faster growth rate during the forecast period. The growth rate witnessed by the Molecular diagnostic technique is attributed to increasing demand for Polymerase Chain Reaction and Isothermal Nucleic Acid Amplification Test. Furthermore, development of assays using this technology like molecular assays, the use of which is supported by WHO, is also contributing to the growth rate witnessed by this segment.
- In regards to Disease Type, the Hepatitis segment occupied the largest market share of more than 20.0% in 2019. The market share held by the Hepatitis diagnostics is attributed to elevating the adoption of developed technologies for hepatitis B diagnosis and high occurrence rate of the condition, particularly among individuals below forty years, which contributes to the market share held by this segment.
- Abbott has been expanding its accessibility to COVID-19 tests by elevating its production and shipping to customers. As of April 2020, the company has been manufacturing 50,000 tests per day.
- In April 2020, E25Bio has developed a rapid antigen test for COVID-19. This test is capable of conducting the COVID-19 test in 15 minutes. Currently, the test is awaiting FDA clearance.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2956
Thank you for reading our report. For further inquiry, please connect with us and our team will make sure the report is customized according to your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
